Dv Biomed Co Stock Working Capital
| 6539 Stock | TWD 68.40 3.30 5.07% |
DV Biomed Co fundamentals help investors to digest information that contributes to DV Biomed's financial success or failures. It also enables traders to predict the movement of 6539 Stock. The fundamental analysis module provides a way to measure DV Biomed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DV Biomed stock.
6539 |
DV Biomed Co Company Working Capital Analysis
DV Biomed's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
In accordance with the company's disclosures, DV Biomed Co has a Working Capital of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The working capital for all Taiwan stocks is 100.0% higher than that of the company.
6539 Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DV Biomed's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DV Biomed could also be used in its relative valuation, which is a method of valuing DV Biomed by comparing valuation metrics of similar companies.DV Biomed is currently under evaluation in working capital category among its peers.
6539 Fundamentals
| Return On Equity | 23.52 | |||
| Return On Asset | 8.85 | |||
| Profit Margin | 16.64 % | |||
| Operating Margin | 14.88 % | |||
| Current Valuation | 3.68 B | |||
| Shares Outstanding | 59.26 M | |||
| Price To Earning | 13.49 X | |||
| Price To Book | 3.33 X | |||
| Price To Sales | 2.22 X | |||
| Revenue | 1.81 B | |||
| Gross Profit | 925.51 M | |||
| EBITDA | 448.99 M | |||
| Net Income | 301.4 M | |||
| Cash And Equivalents | 538.29 M | |||
| Cash Per Share | 9.14 X | |||
| Total Debt | 249.93 M | |||
| Debt To Equity | 0.21 % | |||
| Current Ratio | 2.32 X | |||
| Book Value Per Share | 20.43 X | |||
| Cash Flow From Operations | 463.36 M | |||
| Earnings Per Share | 5.04 X | |||
| Number Of Employees | 316 | |||
| Beta | 0.48 | |||
| Market Capitalization | 4.03 B | |||
| Z Score | 9.6 | |||
| Last Dividend Paid | 1.64 |
About DV Biomed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DV Biomed Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DV Biomed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DV Biomed Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with DV Biomed
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DV Biomed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DV Biomed will appreciate offsetting losses from the drop in the long position's value.Moving together with 6539 Stock
Moving against 6539 Stock
| 0.64 | 1591 | Inmax Holding | PairCorr |
| 0.58 | 2345 | Accton Technology Corp | PairCorr |
| 0.49 | 1795 | Lotus Pharmaceutical | PairCorr |
| 0.44 | 6674 | Compal Broadband Networks | PairCorr |
The ability to find closely correlated positions to DV Biomed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DV Biomed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DV Biomed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DV Biomed Co to buy it.
The correlation of DV Biomed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DV Biomed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DV Biomed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DV Biomed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for 6539 Stock Analysis
When running DV Biomed's price analysis, check to measure DV Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DV Biomed is operating at the current time. Most of DV Biomed's value examination focuses on studying past and present price action to predict the probability of DV Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DV Biomed's price. Additionally, you may evaluate how the addition of DV Biomed to your portfolios can decrease your overall portfolio volatility.